Please login to the form below

Not currently logged in


Uniting the Healthcare Communications Community

The Communiqué brand seeks to raise the bar in healthcare communications by posting up-to-the-minute industry news, insightful articles, agency case studies and sharing best practice. If you are looking to hire a communications agency, our content provides you with a step-by-step guide to choosing and working with the most appropriate agency.

If you are a communications agency, we can help position you in front of your desired clients.

From: Marketing

TBWA\WorldHealth London announces restructure and key hires

TBWASarah Williams, Britt Nyman and Kavita Goswami join as business unit leads

From: Marketing

W2O acquires advertising and medical education agency 21GRAMS

W2O logoAcquisition adds 150 experts to the W2O team


Communiqué Awards 2020 is now open for entry

communique smallThis year's programme sees the introduction of two new categories


GCI Health opens new office in Hong Kong

Yvone YeungWill be led by newly appointed director Yvonne Yeung


Communiqué - Volume 45

Communiqué 45 is available to view online now

Communique magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Join in the chat

Lucid Group names Neil Flash chief commercial officer

Flash joins the team from dna Communications

Neil Flash

How AI is transforming the way we collect market insights

Leveraging new technologies to gather actionable insights

AI market insights

Featured jobs

Subscribe to our email news alerts


Add my company

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...